Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.48 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
| ▸ | MAP2 | P11137 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
| ▸ | GABRD | O14764 | 1/20 | 0.41 |
| ▸ | IKBKB | O14920 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | CHUK | O15111 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | TOP1 | P11387 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1102793 | 1.00 | NOTUM (0.48) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102728 | 1.00 | NOTUM (0.48) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102643 | 1.00 | NOTUM (0.48) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102798 | 0.98 | TNF (0.47) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102677 | 0.98 | TNF (0.47) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102900 | 0.98 | TNF (0.47) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102806 | 0.98 | TNF (0.47) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102490 | 0.96 | TNF (0.48) | NOTUMTNFMAP2MAPK10ACHE | |
| SCHEMBL1102557 | 0.91 | TNF (0.44) | NOTUMTNFMAP2MAPK10KDM4E | |
| SCHEMBL16298675 | 0.91 | ACHE (0.44) | NOTUMTNFMAP2MAPK10ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10950803-B2 | Compounds and uses in devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-16 | — | — | US | disclosed |
| US-20190319194-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-10-17 | — | — | US | disclosed |
| US-20160149139-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-26 | — | — | US | disclosed |
| US-20160149139-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-26 | — | — | US | disclosed |
| US-20160104847-A1 | NOVEL COMPOUNDS AND USES IN DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-04-14 | — | — | US | disclosed |
| US-20160104847-A1 | NOVEL COMPOUNDS AND USES IN DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-04-14 | — | — | US | disclosed |
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| EP-2147962-A1 | Azaanthracene-derivatives and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2010-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD2, OCIAD1 | NOTUM 8/4885TNF 3803/4885MAP2 3311/4885 |
| US-20160104847-A1 | NOVEL COMPOUNDS AND USES IN DEVICES | TERT, UACA, TXN | NOTUM 3919/4885TNF 241/4885MAP2 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.